IP Library › Granted Patent US 12,742,167
Granted Patent B2
US 12,742,167 · App. 17/694,324 · Granted Sep 22, 2026

Systems and methods for biomolecule retention

Inventors: Torri Elise Rinker (San Francisco, CA); Christina Inman (San Mateo, CA); Parag Mallick (San Mateo, CA); Tural Aksel (Redwood City, CA); Stephen Hendricks (Los Gatos, CA); Pierre Indermuhle (Berkeley, CA); Hongji Qian (Sunnyvale, CA); Steven Tan (San Mateo, CA); Elvis Ikwa (San Leandro, CA); Pengyu Hao (Belmont, CA); Sadie Ingle (Suttons Bay, MI)
Assignee: Nautilus Subsidiary, Inc.
C12N15/1093B01J19/0046B82Y5/00C12Q1/6804C12Q1/6837B01J2219/0061
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,742,167
App. No.
17/694,324
Granted
Sep 22, 2026
Kind
B2
Abstract

Compositions, systems, and methods for the display of analytes such as biomolecules are described. Display of analytes is achieved by coupling of the analytes to displaying molecules that are configured to associate with surfaces or interfaces. Arrays of analytes may be formed from the described systems for utilization in assays and other methods.

Claims (38)

1 . A system, comprising:

a) a solid support comprising a plurality of sites, wherein a plurality of nucleic acid particles is attached to the plurality of sites, wherein each site of the plurality of sites is attached to only one nucleic acid particle of the plurality of nucleic acid particles, wherein a plurality of polypeptides is attached to the plurality of nucleic acid particle, wherein each nucleic acid particle of the plurality of nucleic acid particles is attached to only one polypeptide of the plurality of polypeptides, wherein each nucleic acid particle of the plurality of nucleic acid particles comprises a first double-stranded region that is attached to the solid support and a second double-stranded region that is oriented substantially orthogonal to the surface of the solid support, wherein only one polypeptide of the plurality of polypeptides is attached to the second double-stranded region, and wherein each site of the plurality of sites is optically resolvable from any other site of the plurality of sites;

b) a first fluidic medium comprising a first plurality of binding reagents, wherein binding reagents of the first plurality of binding reagents are configured to provide a first optical signal, and wherein the first fluidic medium is deliverable to the solid support;

c) a second fluidic medium comprising a second plurality of binding reagents, wherein binding reagents of the second plurality of binding reagents are configured to provide a second optical signal, wherein the second optical signal is distinguishable from the first optical signal, and wherein the second fluidic medium is deliverable to the solid support; and

d) an optical detector, wherein the optical detector is configured to detect at each individual site of the plurality of sites a presence or an absence of a first optical signal from a binding reagent of the first plurality of binding reagents, and wherein the optical detector is configured to detect at each individual site of the plurality of sites a presence or an absence of a second optical signal from a binding reagent of the second plurality of binding reagents.

2 . The system of claim 1 , wherein the sites of the plurality of sites are separated by at least 500 nanometers.

3 . The system of claim 1 , further comprising a processor that is configured to receive measurements of the presences or absences of the first optical signals and the second optical signals for each site of the plurality of sites from the optical detector.

4 . The system of claim 3 , wherein the processor is configured with an algorithm to characterize the polypeptide at each site of the plurality of sites based upon the measurements of the presences or absences of the first optical signals and the second optical signals for each site of the plurality of sites from the optical detector.

5 . The system of claim 4 , wherein characterizing each polypeptide at each site of the plurality of sites comprises identifying each polypeptide at each site of the plurality of sites.

6 . The system of claim 4 , wherein characterizing each polypeptide at each site of the plurality of sites further comprises quantifying the polypeptides attached to the solid support.

7 . The system of claim 6 , wherein quantifying the polypeptides attached to the solid support comprises quantifying a dynamic range of a first polypeptide species and a second polypeptide species of the plurality of polypeptides.

8 . The system of claim 4 , wherein the algorithm comprises a machine learning algorithm.

9 . The system of claim 1 , wherein the solid support comprises a material selected from the group consisting of ceramic, glass, polymer, and semiconductor.

10 . The system of claim 9 , wherein the solid support further comprises a layer disposed upon the material.

11 . The system of claim 10 , wherein the layer comprises a metal or metal oxide.

12 . The system of claim 11 , wherein the layer has a thickness of at least 10 nanometers.

13 . The system of claim 10 , wherein the layer comprises a plurality of wells, wherein each well of the plurality of wells individually comprises a site of the plurality of sites.

14 . The system of claim 1 , wherein the only one polypeptide is attached to a linking moiety of the nucleic acid particle.

15 . The system of claim 14 , wherein the linking moiety provides a separation distance of at least 10 nanometers between the only one polypeptide and the solid support.

16 . The system of claim 1 , wherein the only one nucleic acid particle comprises a surface-interacting moiety.

17 . The system of claim 16 , wherein the surface-interacting moiety comprises an inorganic nanoparticle, a carbon nanoparticle, a polymer nanoparticle, or a biopolymer.

18 . The system of claim 1 , wherein the optical detector comprises a time delay integration (TDI) device, a complementary metal oxide semiconductor (CMOS) detector, an avalanche photodiode (APD) detector, a Geiger-mode photon counter, a photomultiplier tube (PMT), a charge injection device (CID) sensor, or a JOT image sensor.

19 . The system of claim 1 , wherein the system further comprises a light-emitting source.

20 . The system of claim 19 , wherein the light-emitting source comprises a laser, a light-emitting diode (LED), or a lamp.

21 . The system of claim 1 , wherein the binding reagents of the first plurality of binding reagents have a binding specificity for a first polypeptide species of the plurality of polypeptides.

22 . The system of claim 21 , wherein the binding reagents of the second plurality of binding reagents have a binding specificity for a second polypeptide species of the plurality of polypeptides.

23 . The system of claim 1 , wherein a binding reagent of the first plurality of binding reagents or the second plurality of binding reagents comprises an antibody or an antibody fragment.

24 . The system of claim 1 , wherein a binding reagent of the first plurality of binding reagents or the second plurality of binding reagents comprises an aptamer or a peptamer.

25 . A system, comprising:

a) a solid support comprising a plurality of immobilized nucleic acid particles, wherein the plurality of immobilized nucleic acid particles is attached to a plurality of polypeptides, wherein the plurality of polypeptides comprises a first polypeptide species and a second polypeptide species, wherein the first polypeptide species and the second polypeptide species have a dynamic range of at least 10 4 with respect to each other, wherein each immobilized nucleic acid particle of the plurality of nucleic acid particles comprises a first double-stranded region that is attached to the solid support and a second double-stranded region that is oriented substantially orthogonal to the surface of the solid support, and wherein only one polypeptide of the plurality of polypeptides is attached to the second double-stranded region;

b) a first fluidic medium comprising a first plurality of binding reagents, wherein binding reagents of the first plurality of binding reagents are configured to provide a first optical signal, and wherein the first fluidic medium is deliverable to the solid support;

c) a second fluidic medium comprising a second plurality of binding reagents, wherein binding reagents of the second plurality of binding reagents are configured to provide a second optical signal, wherein the second optical signal is distinguishable from the first optical signal, and wherein the second fluidic medium is deliverable to the solid support; and

d) an optical detector, wherein the optical detector is configured to detect at each individual site of the plurality of sites a presence or an absence of a first optical signal from a binding reagent of the first plurality of binding reagents, and wherein the optical detector is configured to detect at each individual site of the plurality of sites a presence or an absence of a second optical signal from a binding reagent of the second plurality of binding reagents.

26 . A system, comprising:

a) a solid support comprising a plurality of sites, wherein a plurality of nucleic acid particles is attached to the plurality of sites, wherein each site of the plurality of sites is attached to only one nucleic acid particle of the plurality of nucleic acid particles, wherein a plurality of polypeptides is attached to the plurality of nucleic acid particles, wherein each nucleic acid particle is attached to only one polypeptide of the plurality of polypeptides, wherein the plurality of polypeptides comprises a first proteoform of a protein and a second proteoform of the protein, wherein each nucleic acid particle of the plurality of nucleic acid particles comprises a first double-stranded region that is attached to the solid support and a second double-stranded region that is oriented substantially orthogonal to the surface of the solid support, wherein only one polypeptide of the plurality of polypeptides is attached to the second double-stranded region;

b) a first fluidic medium comprising a first plurality of binding reagents, wherein binding reagents of the first plurality of binding reagents have a binding specificity for the first proteoform of the protein, wherein binding reagents of the first plurality of binding reagents are configured to provide a first optical signal, and wherein the first fluidic medium is deliverable to the solid support;

c) a second fluidic medium comprising a second plurality of binding reagents, wherein binding reagents of the second plurality of binding reagents have a binding specificity for the second proteoform of the protein, wherein binding reagents of the second plurality of binding reagents are configured to provide a second optical signal, wherein the second optical signal is distinguishable from the first optical signal, and wherein the second fluidic medium is deliverable to the solid support; and

d) an optical detector, wherein the optical detector is configured to detect at each individual site of the plurality of sites a presence or an absence of a first optical signal from a binding reagent of the first plurality of binding reagents, and wherein the optical detector is configured to detect at each individual site of the plurality of sites a presence or an absence of a second optical signal from a binding reagent of the second plurality of binding reagents.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2025
From: IKWA, ELVIS; INGLE, SADIE; HAO, PENGYU
To: NAUTILUS SUBSIDIARY, INC.
Reel/Frame 073278/0040 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2023
From: NAUTILUS BIOTECHNOLOGY, INC.
To: NAUTILUS SUBSIDIARY, INC.
Reel/Frame 063350/0113 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2022
From: AKSEL, TURAL; HENDRICKS, STEPHEN; INDERMUHLE, PIERRE; INMAN, CHRISTINA; MALLICK, PARAG; QIAN, HONGJI; RINKER, TORRI ELISE; TAN, STEVEN
To: NAUTILUS BIOTECHNOLOGY, INC.
Reel/Frame 059867/0723 →
Continuity (4)
Continuation 17692035 · Mar 10, 2022
Provisional Application 63256761 · Oct 18, 2021
Provisional Application 63159500 · Mar 11, 2021
Related Publication 20220290218A1 · Sep 15, 2022
References Cited (144)
US 5324633A · Fodor et al. · 1994 [cited by applicant]
US 5919626A · Shi et al. · 1999 [cited by applicant]
US 6255469B1 · Seeman et al. · 2001 [cited by applicant]
US 6391625B1 · Park et al. · 2002 [cited by applicant]
US 6589726B1 · Butler et al. · 2003 [cited by applicant]
US 6610482B1 · Fodor et al. · 2003 [cited by applicant]
US 6737236B1 · Pieken et al. · 2004 [cited by applicant]
US 6806361B1 · Kajisa et al. · 2004 [cited by applicant]
US 6824866B1 · Glazer et al. · 2004 [cited by applicant]
US 7148058B2 · Charych et al. · 2006 [cited by applicant]
US 7158224B2 · Montagu · 2007 [cited by applicant]
US 7183054B2 · Myers et al. · 2007 [cited by applicant]
US 7259258B2 · Kozlov et al. · 2007 [cited by applicant]
US 7351528B2 · Landegren · 2008 [cited by applicant]
US 7375234B2 · Sharpless et al. · 2008 [cited by applicant]
US 7427678B2 · Pieken et al. · 2008 [cited by applicant]
US 7598363B2 · Seeman et al. · 2009 [cited by applicant]
US 7635562B2 · Harris et al. · 2009 [cited by applicant]
US 7763736B2 · Sharpless et al. · 2010 [cited by applicant]
US 7794799B1 · Kim et al. · 2010 [cited by applicant]
US 7842793B2 · Rothemund · 2010 [cited by applicant]
US 7855054B2 · Schneider et al. · 2010 [cited by applicant]
US 7955837B2 · Pawlak et al. · 2011 [cited by applicant]
US 7964356B2 · Zichi et al. · 2011 [cited by applicant]
US 8013134B2 · Fredriksson · 2011 [cited by applicant]
US 8133719B2 · Drmanac et al. · 2012 [cited by applicant]
US 8222047B2 · Duffy et al. · 2012 [cited by applicant]
US 8236574B2 · Duffy et al. · 2012 [cited by applicant]
US 8268554B2 · Schallmeiner · 2012 [cited by applicant]
US 8404830B2 · Zichi et al. · 2013 [cited by applicant]
US 8415171B2 · Rissin et al. · 2013 [cited by applicant]
US 8445194B2 · Drmanac et al. · 2013 [cited by applicant]
US 8501923B2 · Rothemund · 2013 [cited by applicant]
US 8685894B2 · Chaput et al. · 2014 [cited by applicant]
US 8877516B2 · Lin et al. · 2014 [cited by applicant]
US 8945811B2 · True · 2015 [cited by applicant]
US 8945830B2 · Heil et al. · 2015 [cited by applicant]
US 8975026B2 · Zichi et al. · 2015 [cited by applicant]
US 8975388B2 · Zichi et al. · 2015 [cited by applicant]
US 9163056B2 · Rohloff et al. · 2015 [cited by applicant]
US 9275871B2 · Sandhu · 2016 [cited by applicant]
US 9330932B1 · Sills et al. · 2016 [cited by applicant]
US 9340416B2 · Maune et al. · 2016 [cited by applicant]
US 9395359B2 · Walt et al. · 2016 [cited by applicant]
US 9404919B2 · Schneider et al. · 2016 [cited by applicant]
US 9466504B1 · Sills et al. · 2016 [cited by applicant]
US 9551663B2 · Rissin et al. · 2017 [cited by applicant]
US 9556360B2 · McGall et al. · 2017 [cited by applicant]
US 9625469B2 · Marcotte et al. · 2017 [cited by applicant]
US 9678068B2 · Duffy et al. · 2017 [cited by applicant]
US 9717685B2 · Shih et al. · 2017 [cited by applicant]
US 9777315B2 · Fredriksson et al. · 2017 [cited by applicant]
US 9796749B2 · Yin et al. · 2017 [cited by applicant]
US 9881786B2 · Sills et al. · 2018 [cited by applicant]
US 9926566B2 · Ochsner et al. · 2018 [cited by applicant]
US 9938314B2 · Rohloff et al. · 2018 [cited by applicant]
US 9975916B2 · Yin et al. · 2018 [cited by applicant]
US 10099920B2 · Shen et al. · 2018 [cited by applicant]
US 10221207B2 · Rohloff et al. · 2019 [cited by applicant]
US 10221421B2 · Jarvis et al. · 2019 [cited by applicant]
US 10239908B2 · Rohloff et al. · 2019 [cited by applicant]
US 10316321B2 · Zichi et al. · 2019 [cited by applicant]
US 10392621B2 · Ochsner et al. · 2019 [cited by applicant]
US 10473654B1 · Mallick · 2019 [cited by applicant]
US 10513535B2 · He et al. · 2019 [cited by applicant]
US 10545153B2 · Marcotte et al. · 2020 [cited by applicant]
US 10550145B2 · Han et al. · 2020 [cited by applicant]
US 10604543B2 · Yin et al. · 2020 [cited by applicant]
US 10646505B2 · Schulz et al. · 2020 [cited by applicant]
US 10741382B2 · Sills et al. · 2020 [cited by applicant]
US 11001606B2 · Tikhomirov et al. · 2021 [cited by applicant]
US 11060135B2 · Bowen et al. · 2021 [cited by applicant]
US 11125748B2 · Gopinath et al. · 2021 [cited by applicant]
US 11162192B2 · Gopinath et al. · 2021 [cited by applicant]
US 11192083B2 · Kraft et al. · 2021 [cited by applicant]
US 11203612B2 · Gremyachinskiy et al. · 2021 [cited by applicant]
US 11235972B2 · Gopalkrishnan et al. · 2022 [cited by applicant]
US 11760997B2 · Aksel et al. · 2023 [cited by applicant]
US 20040209383A1 · Yin et al. · 2004 [cited by applicant]
US 20050054118A1 · Lebrun · 2005 [cited by applicant]
US 20050095577A1 · Yang et al. · 2005 [cited by applicant]
US 20050287523A1 · Letant et al. · 2005 [cited by applicant]
US 20060035220A1 · Tashiro et al. · 2006 [cited by applicant]
US 20090018028A1 · Lindsay et al. · 2009 [cited by applicant]
US 20100069621A1 · Maune et al. · 2010 [cited by applicant]
US 20150004193A1 · Chang et al. · 2015 [cited by applicant]
US 20160060687A1 · Zhu et al. · 2016 [cited by applicant]
US 20160102344A1 · Niemeyer et al. · 2016 [cited by applicant]
US 20170327888A1 · Ong et al. · 2017 [cited by applicant]
US 20180044663A1 · Yan · 2018 [cited by applicant]
US 20180148514A1 · Williams · 2018 [cited by applicant]
US 20190145982A1 · Chee et al. · 2019 [cited by applicant]
US 20190195869A1 · Fan et al. · 2019 [cited by applicant]
US 20190323002A1 · Gopinath et al. · 2019 [cited by applicant]
US 20200082914A1 · Patel et al. · 2020 [cited by applicant]
US 20200090785A1 · Patel et al. · 2020 [cited by applicant]
US 20200286584A9 · Mallick et al. · 2020 [cited by applicant]
US 20200289658A1 · Stephanopoulos et al. · 2020 [cited by applicant]
US 20200318101A1 · Mallick et al. · 2020 [cited by applicant]
US 20200348307A1 · Beierle et al. · 2020 [cited by applicant]
US 20200348308A1 · Chee et al. · 2020 [cited by applicant]
US 20210032775A1 · Golpinath et al. · 2021 [cited by applicant]
US 20210101930A1 · Gremyachinskiy et al. · 2021 [cited by applicant]
US 20210239705A1 · Mallick · 2021 [cited by applicant]
EP 1105529B2 · 2013 [cited by applicant]
EP 3699142A1 · 2020 [cited by applicant]
EP 3498865B1 · 2020 [cited by applicant]
JP 2020514746A · 2020 [cited by applicant]
WO WO2005065814A1 · 2005 [cited by applicant]
WO 2019195633A1 · 2019 [cited by applicant]
WO WO2019211631A1 · 2019 [cited by applicant]
WO WO2019236749A2 · 2019 [cited by examiner]
WO WO2020106889A1 · 2020 [cited by applicant]
WO WO2020223368A1 · 2020 [cited by applicant]
WO WO2021087402A1 · 2021 [cited by applicant]
WO WO2020254684A1 · 2021 [cited by applicant]
Angelin, A. et al., “Multiscale Origami Structures as Interface for Cells,” Angewandte Chemie International Edition, Dec. 2015, vol. 54, No. 52, pp. 15813-15817. [cited by applicant]
Cutler, et al., J. Amer. Chem. Soc., 134: 1376-1391 (2012). [cited by applicant]
Derr, et al., Science, 338, 662-665 (2012). [cited by applicant]
Drmnac, et al., Science, 327: 78-81 (2010). [cited by applicant]
Gopinath, et al., [cited by applicant]
Hookway et al., “Aggregate formation and suspension culture of human pluripotent stem cells and differentiated progeny”, [cited by applicant]
Jaekel, A. et al., “Manipulating Enzymes Properties with DNA Nanostructures” Molecules 24(20):3694 (2019). [cited by applicant]
Jensen, J.O. et al. “Nanoengineered Bioplatforms Based on DNA Origami [Point of View]” Proceedings of the IEEE 102:1046-1049 (2014). [cited by applicant]
Kolb, H.C. et al., “Click Chemistry: Diverse Chemical Function from a Few Good Reactions” Angewandte Chemie International Edition. 40 (11): 2004ñ2021 (2001). [cited by applicant]
Rissin, et al., Nat. Biotech., 28: 595-599 (2010). [cited by applicant]
Rothemund et al., “Folding DNA to create nanoscale shapes and patterns”, Nature Mar. 16, 2006; 440(7082):297-300 (2006). [cited by applicant]
Spicer, C.D. et al. “Achieving Controlled BiomoleculeñBiomaterial Conjugation” Chem. Rev. (2018) 118(16):7702-7743. [cited by applicant]
Stawicki, C.M. et al., “Modular fluorescent nanoparticle DNA probes for detection of peptides and proteins” Scientific Reports 11:19921 (2021) [doi.org-10.1038-s41598-021-99084-4]. [cited by applicant]
Swaminathan et al., “Highly parallel single-molecule identification of proteins in zeptomole-scale mixtures”, Nat Biotechnol 36, 1076-1082 (2018). https:--doi.org-10.1038-nbt.4278. [cited by applicant]
Vauquelin, G. et al., “Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands” British Journal of Pharmacology 168:1771-1785 (2013). [cited by applicant]
Yang, et al. Angewandte Chemie Int. Ed., 10.1002-anie.202107829, (2021). [cited by applicant]
Yang, et al., “Self-assembly of highly ordered DNA origami lattices at solid-liquid interfaces by controlling cation binding and exchange”, Nano Res. Lett., 13, 3142-3150 (2020). [cited by applicant]
Zakeri, B. et al., “Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin” PNAS 109 (12): E690-E697 (2012). [cited by applicant]
Zhang, P. et al., “Capturing transient antibody conformations with DNA origami epitopes” Nature Communications 11:3114 (2020). [cited by applicant]
Zhao, Z. et al., “Organizing DNA origami tiles into larger structures using preformed scaffold frames” NanoLetters 11:2997-3002 (2011). [cited by applicant]
WO International Search Report and Written Opinion for International Patent Application No. PCT/US2022/019831, 15 pages. Jul. 6, 2022. [cited by applicant]
Xu, Weidong et al., “Super-resolution Geometric Barcoding for Multiplexed miRNA Profiling”, Angewandte Chemie International Edition, vol. 57, No. 43, Oct. 4, 2018, pp. 14075-14079. [cited by applicant]
Xu, Weidong et al., “Supporting Information Super-resolution Geometric Barcoding for Multiplexed miRNA Profiling”, Angewandte Chemie, Oct. 22, 2018, figure S2. [cited by applicant]
Weinrich et al., “Applications of Protein Biochips in Biomedical and Biotechnological Research”, Agnew. Chem. Int. Ed. 2009, 48: 7744-7751. [cited by applicant]
Office Action in CN202280034599.3, mailed Apr. 11, 2026, 15 pages. [cited by applicant]
Office Action in CA3209038, mailed Feb. 26, 2026, 5 pages. [cited by applicant]
Office Action in JP 2023-555255, mailed Feb. 24, 2026, 13 pages. [cited by applicant]
Timp, Winston, et al., “Beyond mass spectrometry, the next step in proteomics”, Science Advances, vol. 6, No. 2, pp. 1-17 (2020). [cited by applicant]